Back to results
US 5,595,974 AGranted
Medicaments for the treatment of restenosis and arterial sclerosis
AssigneeTobishi Pharmaceutical Co., Ltd.
InventorTakanobu Tomaru
Life of this patent
Estimating the term…
Abstract
A medicament for the treatment and/or prophylaxis of restenosis and arterial sclerosis after percutaneous transluminal angioplasty, characterized in that the medicament contains batroxobin as an effective component.
Claims6
A method for the treatment or prophylaxis of restenosis and arterial sclerosis after percutaneous transluminal angioplasty, which comprises administering an effective amount of batroxobin to a patient in need thereof.
Dependencies are inferred from the claim text.